HomeProductsBioactive CompoundsProtein Kinase TargetsTAM ReceptorBemcentinib
Chemical structure of CAS 1037624-75-1

Bemcentinib

CAS No.1037624-75-1
MDL No.MFCD21608463
MFC30H34N8
MW506.60
InChI KeyKXMZDGSRSGHMMK-VWLOTQADSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1037624-75-1
Product NameBemcentinib

Biological Targets

AXL

Associated Conditions

colorectal cancer·COVID-19·lung adenocarcinoma·pancreatic carcinoma·neoplasm·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Phosphatidylserine receptors enhance SARS-CoV-2 infection.

PLoS pathogens • Vol. 17, Issue 11 • 2021
PMID: 34797899PMC: PMC8641883DOI: 10.1371/journal.ppat.1009743

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.

BMC cancer • Vol. 21, Issue 1 • 2021
PMID: 34140003PMC: PMC8210361DOI: 10.1186/s12885-021-08450-y

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.

Cell reports • Vol. 35, Issue 1 • 2021
PMID: 33811811PMC: PMC7985926DOI: 10.1016/j.celrep.2021.108959

AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective.

Journal of medicinal chemistry • Vol. 59, Issue 8 • 2016
PMID: 26555154DOI: 10.1021/acs.jmedchem.5b01273

Documentation